Columbia, SC, United States of America

Jing Li

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Columbia, SC (US) (2021)
  • West Columbia, SC (US) (2023)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Jing Li - Pioneering Cancer Therapy Innovations

Introduction:

Jing Li, a prolific inventor based in Columbia, SC, has made significant contributions to the field of cancer therapy through his groundbreaking patents and research endeavors. With a portfolio boasting two patents, Jing Li is paving the way for novel treatment modalities in the fight against cancer.

Latest Patents:

1. Bicyclic Pyridine Compositions for Cancer Therapy: Jing Li's inventive work includes the development of bicyclic pyridine compounds such as thienopyridine, pyrrolopyridine, furopyridine, aimed at treating various forms of cancer. These innovative compounds offer promising methods for combating the complexities of cancer through unique therapeutic approaches.

2. Quinoline-Based Compounds for CDK8/19 Inhibition: Another patent by Jing Li focuses on quinoline-based compounds designed to inhibit CDK8 or CDK19, thus offering interventions in a spectrum of diseases, disorders, and conditions. This patent highlights his commitment to exploring diverse avenues for addressing critical medical challenges.

Career Highlights:

Jing Li has leveraged his expertise while working with esteemed institutions such as the University of South Carolina and Senex Biotechnology, Inc. His innovative research initiatives have garnered acclaim, positioning him as a frontrunner in the oncology research landscape.

Collaborations:

Throughout his career, Jing Li has collaborated with notable peers in the field, including Igor B Roninson and Campbell McInnes. These collaborations have not only enriched his work but have also fostered a culture of shared knowledge and innovation within the scientific community.

Conclusion:

In conclusion, Jing Li's inventive spirit and unwavering commitment to advancing cancer therapy highlight the critical role of innovators in shaping the future of healthcare. His patents stand as testaments to his dedication to revolutionizing treatment methodologies, offering hope to patients and practitioners alike in the ongoing battle against cancer. Jing Li's contributions serve as a beacon of inspiration for future generations of inventors and researchers in the quest for innovative solutions to complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…